Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR)

CUSIP: 86366E106

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Ordinary Shares, par value $0.0001 per share
Shares outstanding
213,001,347
Total 13F shares
61,353,442
Share change
+2,340,630
Total reported value
$2,685,754,151
Put/Call ratio
80%
Price per share
$43.89
Number of holders
160
Value change
+$108,882,886
Number of buys
94
Number of sells
66

Quarterly Holders Quick Answers

What is CUSIP 86366E106?
CUSIP 86366E106 identifies GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
3.5%
7,547,920
$296,406,819 30 Jun 2024
13F
FMR LLC
13F
Company
2.7%
5,744,809
$225,598,649 30 Jun 2024
13F
JANUS HENDERSON GROUP PLC
13F
Company
1.6%
3,354,269
$131,649,761 30 Jun 2024
13F
Capital Research Global Investors
13F
Company
1.5%
3,131,310
$122,966,544 30 Jun 2024
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
1.2%
2,577,136
$101,204,131 30 Jun 2024
13F
BVF INC/IL
13F
Company
1.2%
2,487,762
$97,694,414 30 Jun 2024
13F
FEDERATED HERMES, INC.
13F
Company
1.1%
2,407,206
$94,530,980 30 Jun 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
1.1%
2,313,521
$90,852,000 30 Jun 2024
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
0.89%
1,896,772
$74,486,236 30 Jun 2024
13F
Capital International Investors
13F
Company
0.7%
1,498,644
$58,851,750 30 Jun 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.66%
1,408,385
$55,307,279 30 Jun 2024
13F
FIL Ltd
13F 3/4/5
Company · Other*
0.61%
1,307,968
$51,363,904 30 Jun 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.57%
1,213,099
$47,638,398 30 Jun 2024
13F
Octagon Capital Advisors LP
13F
Company
0.54%
1,140,060
$44,770,156 30 Jun 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.53%
1,139,292
$44,739,997 30 Jun 2024
13F
Logos Global Management LP
13F
Company
0.52%
1,100,000
$43,197,000 30 Jun 2024
13F
Avidity Partners Management LP
13F
Company
0.5%
1,075,000
$42,215,250 30 Jun 2024
13F
Rock Springs Capital Management LP
13F
Company
0.47%
999,862
$39,264,581 30 Jun 2024
13F
Deep Track Capital, LP
13F
Company
0.45%
950,000
$37,306,500 30 Jun 2024
13F
BlackRock Finance, Inc.
13F
Company
0.44%
943,019
$37,032,356 30 Jun 2024
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
0.4%
844,407
$33,159,863 30 Jun 2024
13F
Alyeska Investment Group, L.P.
13F
Company
0.33%
707,390
$27,779,205 30 Jun 2024
13F
Casdin Capital, LLC
13F
Company
0.33%
700,000
$27,489,000 30 Jun 2024
13F
T. Rowe Price Investment Management, Inc.
13F
Company
0.33%
696,498
$27,352,000 30 Jun 2024
13F
TCG Crossover Management, LLC
13F
Company
0.33%
694,547
$27,274,861 30 Jun 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.32%
682,363
$26,796,395 30 Jun 2024
13F
FRANKLIN RESOURCES INC
13F
Company
0.3%
645,709
$25,357,012 30 Jun 2024
13F
First Light Asset Management, LLC
13F
Company
0.28%
590,647
$23,194,708 30 Jun 2024
13F
Vestal Point Capital, LP
13F
Company
0.26%
560,000
$21,991,200 30 Jun 2024
13F
Bellevue Group AG
13F
Company
0.26%
557,321
$21,885,996 30 Jun 2024
13F
Ramy Farid
3/4/5
Director
mixed-class rows
3,535,495
mixed-class rows
$17,176,500 07 Feb 2023
AMERICAN CENTURY COMPANIES INC
13F
Company
0.2%
434,982
$17,081,762 30 Jun 2024
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.19%
406,844
$15,976,764 30 Jun 2024
13F
MONEY CONCEPTS CAPITAL CORP
13F
Company
0.19%
400,959
$15,745,660 30 Jun 2024
13F
Boxer Capital, LLC
13F
Company
0.19%
400,000
$15,708,000 30 Jun 2024
13F
Point72 Asset Management, L.P.
13F
Company
0.17%
367,679
$14,438,754 30 Jun 2024
13F
Woodline Partners LP
13F
Company
0.16%
337,401
$13,249,737 30 Jun 2024
13F
Capital World Investors
13F
Company
0.15%
323,760
$12,714,055 30 Jun 2024
13F
JENNISON ASSOCIATES LLC
13F
Company
0.15%
314,503
$12,350,532 30 Jun 2024
13F
FRED ALGER MANAGEMENT, LLC
13F
Company
0.14%
287,636
$11,295,466 30 Jun 2024
13F
HSG Holding Ltd
13F
Company
0.12%
266,062
$10,283,297 30 Jun 2024
13F
ArrowMark Colorado Holdings LLC
13F
Company
0.11%
242,900
$9,538,683 30 Jun 2024
13F
Invesco Ltd.
13F
Company
0.11%
237,974
$9,345,239 30 Jun 2024
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.1%
216,413
$8,498,537 30 Jun 2024
13F
TD ASSET MANAGEMENT INC
13F
Company
0.1%
211,590
$8,309,139 30 Jun 2024
13F
Ensign Peak Advisors, Inc
13F
Company
0.09%
183,785
$7,217,237 30 Jun 2024
13F
Zimmer Partners, LP
13F
Company
0.08%
177,100
$6,954,717 30 Jun 2024
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.08%
165,244
$6,489,123 30 Jun 2024
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
0.07%
144,500
$5,674,515 30 Jun 2024
13F
S.c.a. Candriam
13F
Individual
0.06%
135,000
$5,301,203 30 Jun 2024
13F

Institutional Holders of Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR) as of Q3 2024

As of 30 Sep 2024, Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR) was held by 160 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 61,353,442 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, JANUS HENDERSON GROUP PLC, Capital Research Global Investors, Driehaus Capital Management LLC, FEDERATED HERMES, INC., BVF INC/IL, PRICE T ROWE ASSOCIATES INC /MD/, RA CAPITAL MANAGEMENT, L.P., and Capital International Investors. This page lists 160 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
164
Q3 2024 holders
160
Holder diff
-4
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 Value $ Q3 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .